Lisata Therapeutics (LSTA) Equity Ratio (2016 - 2025)
Historic Equity Ratio for Lisata Therapeutics (LSTA) over the last 13 years, with Q3 2025 value amounting to 0.8.
- Lisata Therapeutics' Equity Ratio fell 947.12% to 0.8 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.8, marking a year-over-year decrease of 947.12%. This contributed to the annual value of 0.84 for FY2024, which is 403.02% down from last year.
- According to the latest figures from Q3 2025, Lisata Therapeutics' Equity Ratio is 0.8, which was down 947.12% from 0.84 recorded in Q2 2025.
- Over the past 5 years, Lisata Therapeutics' Equity Ratio peaked at 0.93 during Q2 2023, and registered a low of 0.8 during Q3 2025.
- Its 3-year average for Equity Ratio is 0.88, with a median of 0.88 in 2024.
- Over the last 5 years, Lisata Therapeutics' Equity Ratio had its largest YoY gain of 183.96% in 2025, and its largest YoY loss of 947.12% in 2025.
- Lisata Therapeutics' Equity Ratio (Quarter) stood at 0.88 in 2023, then fell by 4.03% to 0.84 in 2024, then fell by 5.49% to 0.8 in 2025.
- Its Equity Ratio was 0.8 in Q3 2025, compared to 0.84 in Q2 2025 and 0.87 in Q1 2025.